AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions.
Yasuda K, Shimodan S, Maehara N, Hirota A, Iijima R, Nishijima A, Mori H, Toyama R, Ito A, Yoshikawa Y, Arai S, Miyazaki T.
Yasuda K, et al. Among authors: toyama r.
J Autoimmun. 2024 Jan;142:103149. doi: 10.1016/j.jaut.2023.103149. Epub 2023 Nov 25.
J Autoimmun. 2024.
PMID: 38006711
Free article.